首页 | 本学科首页   官方微博 | 高级检索  
     

FLAG联合改良BUCY预处理方案的异基因造血干细胞移植治疗难治复发恶性血液病疗效分析
引用本文:王志红,吴晓雄,刘周阳,马健,曹永彬,徐丽昕,吴亚妹,刘蓓,闫蓓,达万明. FLAG联合改良BUCY预处理方案的异基因造血干细胞移植治疗难治复发恶性血液病疗效分析[J]. 中国实验血液学杂志, 2011, 19(1): 158-162
作者姓名:王志红  吴晓雄  刘周阳  马健  曹永彬  徐丽昕  吴亚妹  刘蓓  闫蓓  达万明
作者单位:1. 解放军总医院第304临床部血液科,北京,100048
2. 解放军总医院血液科,北京,100853
摘    要:本研究旨在观察应用FLAG联合改良的BUCY预处理方案行异基因造血干细胞移植治疗难治复发或高危恶性血液病的疗效。对10例难治复发或高危恶性血液病患者自愿接受FLAG联合改良的BUCY预处理的异基因造血干细胞移植的疗效进行分析。10例中复发2例(早期复发1例,淋巴瘤进展1例),难治7例(2例CR2,1例CR3,2例PR,2例NR),1例CR1但为高危病例。10例患者中包括急性髓性白血病8例(M11例,M25例,M61例,恶性骨髓增生异常综合征伴骨髓纤维化1例),前T淋巴母细胞淋巴瘤/白血病1例,脾边缘带淋巴瘤IVB1例。结果表明,10例全部顺利植入,10例患者除2例死亡(1例死于肺部感染,1例死于真菌肺炎、渗漏综合征、多脏器功能衰竭),其余8例无复发,中位生存时间为164天(57-442天)。结论:应用FLAG联合改良的BUCY预处理方案(清肿瘤性方案)的异基因造血干细胞移植治疗难治复发或高危的恶性血液病可取得良好的疗效。

关 键 词:异基因造血干细胞移植  FLAG方案  Bucy方案  白血病  淋巴瘤

Curative Efficacy Analysis of Allo-HSCT Using Conditioning Regimen of FLAG Combined with Modified BUCY for Refractory and Relapsed Patients with Hematologic Malignancies
WANG Zhi-Hong,WU Xiao-Xiong,LIU Zhou-Yang,MA Jian,CAO Yong-Bin,XU Li-Xin,WU Ya-Mei,LIU Bei,YAN Bei,DA Wan-Ming. Curative Efficacy Analysis of Allo-HSCT Using Conditioning Regimen of FLAG Combined with Modified BUCY for Refractory and Relapsed Patients with Hematologic Malignancies[J]. Journal of experimental hematology, 2011, 19(1): 158-162
Authors:WANG Zhi-Hong  WU Xiao-Xiong  LIU Zhou-Yang  MA Jian  CAO Yong-Bin  XU Li-Xin  WU Ya-Mei  LIU Bei  YAN Bei  DA Wan-Ming
Affiliation:WANG Zhi-Hong,WU Xiao-Xiong,LIU Zhou-Yang,MA Jian,CAO Yong-Bin,XU Li-Xin,WU Ya-Mei,LIU Bei,YAN Bei,DA Wan-Ming1Department of Hematology,Clinical Division 304,Chinese PLA General Hospital,Beijing 100048,China,1Department of Hematology,Beijing 100853
Abstract:This study was aimed to investigate the curative efficacy of allogenetic hemopoietic stem cell transplan-tation(allo-HSCT) using FLAG and modified BUCY conditioning regimen for patients with refractory and relapse or high risk hematologic malignancies.The therapeutic effect of allo-HSCT with FLAG and modified BUCY conditioning regimen on 10 patients with hematologic malignancies was analyzed.10 patients included 2 cases of relapse(1 early relapse,1 progressoin) and 7 cases of refractory(2 CR2,1 CR3 and 2 PR...
Keywords:allogeneic hematopoietic stem cell transplantation  FLAG regimen  Bucy regimen  leukemia  lymphoma  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号